In vitro antifungal susceptibility testing of filamentous fungi with Sensititre Yeast One™

Mycoses

Volumn 49, Issue 4, 2006, Pages 293-297

  Carrillo Munoz A J ^a   Quindos G ^b   Ruesga, M ^b   Del Valle, O ^c   Peman J ^d   Canton E ^d   Hernandez Molina J M ^e   Santos, P ^f  

^a Associacio Catalana d'Intelligencia Artificial   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

^e HOSPITAL LA INMACULADA   (Spain)

^f HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

Amphotericin B; Itraconazole; Ketoconazole; Sensititre

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOROLAC;

ANTIBIOTIC SENSITIVITY; ARTICLE; ASPERGILLUS; COLORIMETRY; CONIDIUM; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; DILUTION; FEASIBILITY STUDY; FUSARIUM; IN VITRO STUDY; INCUBATION TEMPERATURE; INCUBATION TIME; INOCULATION; NONHUMAN; PRIORITY JOURNAL; SCEDOSPORIUM; SPORANGIUM; STANDARD; TEMPERATURE DEPENDENCE; YEAST;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLUS; COLORIMETRY; FUNGI; MICROBIAL SENSITIVITY TESTS;

ASPERGILLUS; ASPERGILLUS FUMIGATUS; FUNGI; FUSARIUM; PSEUDALLESCHERIA BOYDII; SCEDOSPORIUM; SCEDOSPORIUM PROLIFICANS;

EID: 33745153050     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2006.01250.x     Document Type: Article

References (27)

1. Rex JH Pfaller MA Rinaldi MG Polak A Galgiani JN. Antifungal susceptibility testing. Clin Microbiol Rev 1993 6 : 367 81.
2. Rubio Calvo MC Gil Tomás J Benito Ruesca R. Las pruebas in vitro en la evaluación de los agentes antifúngicos. Rev Esp Quimioter 1993 6 : 21.
3. Pemán García J Cantón-Lacasa E. Las pruebas de sensibilidad antifúngica en un laboratorio de microbiología clínica. Rev Esp Quimioter 1996 9 : 17 20.
4. Odds FC. Should resistance to azole antifungals in vitro be interpreted as predicting clinical non-response Drug Resist Updat 1998 1 : 11 15.
5. Espinel-Ingroff A. Clinical utility of in vitro antifungal susceptibility testing. Rev Iberoam Micol 2000 13 : 161 6.
6. Odds FC. Personal opinion: can antifungal sensitivity tests predict clinical treatment outcomes Rev Iberoam Micol 1997 14 : 83 84.
7. LaRocco MT Burgert SJ. Fungal infections in the transplant recipient and laboratory methods for diagnosis. Rev Iberoam Micol 1997 14 : 143 6.
8. Beck-Sague C Jarvis WR, the National Nosocomial Infection Surveillance System. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J Infect Dis 1993 167 : 1247 51.
9. Rüchel R. Mycotic infections in the immunocompromised patient. Rev Iberoam Micol 1996 13 (Suppl. 1) : 20 4.
10. Trick WE Jarvis WR. Epidemiology of nosocomial fungal infections in the 1990s. Rev Iberoam Micol 1998 15 : 2 6.
11. Espinel-Ingroff A Warnock DW Vazquez JA Arthimgton-Skaggs BA. In vitro antifungal susceptibility methods and clinical implications of antifungal resistance. Med Mycol 2000 38 : 293 304.
12. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. M-27A. Villanova, PA : National Committee for Clinical Laboratory Standards, 1997.
13. Espinel-Ingroff A Bartlett M Bowden R et al. Multicenter evaluation of proposed standardization procedure for antifungal susceptibility testing of filamentous fungi. J Clin Microbiol 1997 35 : 139 43.
14. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Conidium Forming Filamentous Fungi. Proposed Standard M38-P. Wayne, PA : National Committee for Clinical Laboratory Standards, 1998.
15. Odds FC Van Gerven F Espinel-Ingroff A et al. Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models. Antimicrob Agents Chemother 1998 42 : 282 8.
16. Guarro J Pujol I Mayayo E. In vitro and in vivo experimental activities of antifungal agents against Fusarium solani. Antimicrob Agents Chemother 1999 43 : 1256 7.
17. Espinel-Ingroff A. Germinated and nongerminated conidial suspensions for testing of susceptibilities of Aspergillus spp. To amphotericin B, itraconazole, posaconazole, ravuconazole and voriconazole. Antimicrob Agents Chemother 2001 5 : 605 7.
18. Espinel-Ingroff A. Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi. J Clin Microbiol 2001 39 : 1360 7.
19. Espinel-Ingroff A. Comparison of in vitro activities of the new triazole SCH56592 and echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol ( 1998) 1998 2950 6.
20. Carrillo-Muñoz AJ Pemán J Gobernado M. Nuevos antifúngicos. Rev Esp Quimioter 1999 12 : 181 204.
21. Carrillo-Muñoz AJ Brió S Quindós G. Una nueva generación de fármacos antifúngicos. Rev Iberoam Micol 2000 18 : 4 7.
22. Pfaller MA Vu Q Lancaster M et al. Multisite reproducibility of colorimetric broth microdilution method for antifungal susceptibility testing of yeasts isolates. J Clin Microbiol 1994 32 : 1625 8.
23. To WK Fothergill AW Rinaldi MG. Comparative evaluation of macrodilution and Alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates. J Clin Microbiol 1995 33 : 2660 4.
24. Messer SA Pfaller MA. Clinical evaluation of a dried commercially prepared microdilution panel for antifungal susceptibility testing. Diagn Microbiol Infect Dis 1996 25 77 81.
25. Arikan S Gur D Akova M. Comparison of E-test, microdilution and colorimetric dilution with reference broth macrodilution method for antifungal susceptibility testing of clinically significant Candida species isolated from immunocompromised patients. Mycoses 1997 40 : 291 6.
26. Espinel-Ingroff A. Clinical utility of in vitro antifungal susceptibility testing. Rev Esp Quimioter 2000 13 : 161 6.
27. Manavathu EK Cutright JL Loebenberh D Chandrasekar PH. A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH56592). J Antimicrob Chemother 2000 46 : 229 34.